G1 Therapeutics
Price & Volume
Stats
See more52W Range | $1.08-$7.19 |
Market Cap | $377.2M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $58.1M |
Revenue Growth (YoY) | -61% |
Gross Profit (12 Mos) | $47.5M |
Diluted EPS | -$0.86 |
News
See moreYahoo Finance • 9 months ago
G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Yahoo Finance • 10 months ago
G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium
Yahoo Finance • 11 months ago
G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights
About
CEO | Mr. John E. Bailey Jr. |
Address | 700 Park Offices Drive, Research Triangle Park, NC, United States, 27709 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |
